US health agencies sound warning on J&J talc bankruptcy
Two U.S. federal health agencies have objected to Johnson & Johnson's $10 billion proposed settlement of tens of thousands of ...
J&J Talc Deal Should Be Rejected in Bankruptcy, Holdouts Say
Holdout creditors who claim tainted baby powder gave them ovarian cancer urged a judge to reject Johnson & Johnson’s plan to ...
FiercePharma2d
US government agencies file objection to J&J's $9B talc bankruptcy settlement
Two attempts by Johnson & Johnson to resolve approximately 60,000 talcum powder lawsuits through bankruptcy courts have ...
J&J talc claimants urge judge to reject $8B settlement, bankruptcy plan
Claims against J&J for cancer caused by talc products may not be settled due to opposition, average payouts, trust ...
J&J-Backed Medtech Firm HistoSonics Considers US IPO
HistoSonics Inc., a medical device company whose backers include Johnson & Johnson’s venture capital arm, is weighing a US ...
Judge dismisses 2 counts in J&J pharmacy benefits lawsuit over upcharged drugs
In its motion to dismiss, J&J asserted that the plaintiff did “not allege a concrete harm or injury-in-fact” — a claim with ...
J&J's ketamine-derived nasal spray approved by FDA to treat depression
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...
Johnson & Johnson stock down despite beat on full-year, Q4 2024 earnings
Johnson & Johnson ( JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to ...
U.S. Trustee, Insurers, Object to J&J's $10B Talc Bankruptcy Plan
Objections to Johnson & Johnson's talc bankruptcy plan cite the U.S. Supreme Court's decision last year invalidating nonconsensual releases in Purdue Pharma's $6 billion opioid settlement.